Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Classical hematology 1

Conditions

Neoplasms 3Pain, Intractable 2Cancer Pain 2Spinal Surgery 1Pain Related to Cancer 1Mucositis 1Leukemia 1Breast Neoplasms 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1Adenocarcinoma 1

Interventions

Ketamine 3Morphine 2Methadone 2resiniferatoxin 1Standard of Care 1Sodium Chloride 1Passive Cutaneous Anaphylaxis 1Hydromorphone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Pain, Intractable × Methadone × Clear all
NCT06940570 2025-10-23

MATCH

University of Texas Southwestern Medical Center

Phase 3 Suspended
60 enrolled
Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

NCT02687347 2016-09-20

UDOME

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 3 Unknown
204 enrolled

Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡